News
Digital and AutomationR&D project spotlight: Advancing automated manufacturing in cell and gene therapies
Regulatory Round-up - April 2026Stratosvir secures support from Cell and Gene Therapy Catapult to advance innovative anticancer therapeuticsRegulatory Round-up - March 2026New survey shows UK cell and gene therapy industry expects workforce to return to growth, following a challenging period of headcount reductionsRegulatory Round-up - February 2026Cross sector collaboration is vital to bringing more life-changing therapies to people with rare diseasesCGT Catapult establishes Technology Advisory Board to identify opportunities for the advanced therapies sector to deploy and benefit from innovationsRegulatory Round-up - January 2026R&D project spotlight: Leveraging advanced analytics for detailed process characterisation in iPSC natural killer cell therapy generationNew data shows continued growth in advanced therapy clinical trials in the UK for 2025, with the number of early-stage trials remaining highRegulatory Round-up - December 2025Minaris and Cell and Gene Therapy Catapult announce collaboration to advance delivery methods for cell and gene therapies